A common site within factor H SCR 7 responsible for binding heparin, C-reactive protein and streptococcal M protein

被引:130
作者
Giannakis, E
Jokiranta, TS
Male, DA
Ranganathan, S
Ormsby, RJ
Fischetti, VA
Mold, C
Gordon, DL [1 ]
机构
[1] Flinders Med Ctr, Dept Microbiol & Infect Dis, Bedford Pk, SA 5042, Australia
[2] Univ New Mexico, Dept Mol Genet & Microbiol, Albuquerque, NM 87131 USA
[3] Rockefeller Univ, New York, NY 10021 USA
[4] Natl Univ Singapore, Dept Biochem, Singapore 117548, Singapore
[5] Natl Univ Singapore, Bioinformat Ctr, Singapore 117548, Singapore
[6] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore
[7] Univ Helsinki Hosp, HUCH Diagnost, Helsinki, Finland
[8] Univ Helsinki Hosp, Haartman Inst, Helsinki, Finland
[9] Univ Helsinki Hosp, Dept Bacteriol & Immunol, Helsinki, Finland
关键词
alternative pathway; complement; streptococcus;
D O I
10.1002/eji.200323541
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The complement inhibitor factor H (fH) interacts via its seventh short consensus repeat (SCR) domain with multiple ligands including heparin, streptococcal M protein and C-reactive protein (CRIP). The aim of this study was to localize the residues in SCR 7 required for these interactions. We initially built a homology model of fH SCR 6-7 using the averaged NMR structures of fH SCR 15-16 and vaccinia control protein SCR 3-4 as templates. Electrostatic potentials of the model's surface demonstrated a co-localization of three clusters of positively charged residues on SCR 7, labeled site A (R369 and K370), site B (R386 and K387) and site C (K392). These residues, localized to the linker region preceding SCR 7 and to the end of a "hypervariable loop" in SCR 7, were systematically replaced with uncharged alanine residues in an fH construct containing SCR 1-7. The resulting proteins were expressed in the methylotrophic yeast, Pichia pastoris. By ELISA analysis we demonstrated: first, that substituting site A inhibited heparin and CRP binding; secondly, that substituting site B inhibited binding to heparin, CRP and M protein; and thirdly, that substituting site C clearly inhibited only heparin binding.
引用
收藏
页码:962 / 969
页数:8
相关论文
共 57 条
[51]   The physiological structure of human C-reactive protein and its complex with phosphocholine [J].
Thompson, D ;
Pepys, MB ;
Wood, SP .
STRUCTURE, 1999, 7 (02) :169-177
[52]  
Villoutreix BO, 1998, PROTEINS, V31, P391, DOI 10.1002/(SICI)1097-0134(19980601)31:4<391::AID-PROT6>3.0.CO
[53]  
2-L
[54]   The complement regulator C4b-binding protein analyzed by molecular modeling, bioinformatics and computer-aided experimental design [J].
Villoutreix, BO ;
Blom, AM ;
Webb, J ;
Dahlbäck, B .
IMMUNOPHARMACOLOGY, 1999, 42 (1-3) :121-134
[55]   INTERACTION OF C-REACTIVE PROTEIN WITH ARTIFICIAL PHOSPHATIDYLCHOLINE BILAYERS [J].
VOLANAKIS, JE ;
WIRTZ, KWA .
NATURE, 1979, 281 (5727) :155-157
[56]   NMR studies of a viral protein that mimics the regulators of complement activation [J].
Wiles, AP ;
Shaw, G ;
Bright, J ;
Perczel, A ;
Campbell, ID ;
Barlow, PN .
JOURNAL OF MOLECULAR BIOLOGY, 1997, 272 (02) :253-265
[57]   The factor H protein family [J].
Zipfel, PF ;
Jokiranta, TS ;
Hellwage, J ;
Koistinen, V ;
Meri, S .
IMMUNOPHARMACOLOGY, 1999, 42 (1-3) :53-60